Wilson Bryan, former FDA gene therapy leader, joins consulting firm
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Celia Witten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.